Alliancebernstein L.P. Tenaya Therapeutics, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 49,570 shares of TNYA stock, worth $47,091. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,570
Previous 49,570
-0.0%
Holding current value
$47,091
Previous $95,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
94Shares Held
60.5MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$8.93 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$6.63 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$6.4 Million1.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$4.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$3.87 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $39.3M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...